These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. High impact of rejection therapy on the incidence of post-transplant diabetes mellitus after kidney transplantation. Schweer T; Gwinner W; Scheffner I; Schwarz A; Haller H; Blume C Clin Transplant; 2014 Apr; 28(4):512-9. PubMed ID: 24649873 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liu CL; Fan ST; Lo CM; Chan SC; Ng IO; Lai CL; Wong J Liver Transpl; 2004 Jun; 10(6):728-33. PubMed ID: 15162466 [TBL] [Abstract][Full Text] [Related]
19. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial. Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153 [TBL] [Abstract][Full Text] [Related]
20. New-onset diabetes mellitus after kidney transplantation: the role of immunosuppression. Veroux M; Corona D; Giuffrida G; Gagliano M; Sorbello M; Virgilio C; Tallarita T; Zerbo D; Giaquinta A; Fiamingo P; Macarone M; Li Volti G; Caglia P; Veroux P Transplant Proc; 2008; 40(6):1885-7. PubMed ID: 18675079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]